Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

Affiliations

¹ Health Equity and Rural Outreach Innovation Center (HEROIC), Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC; Department of Medicine, Thoracic Oncology Research Group, Medical University of South Carolina, Charleston, SC. Electronic address: tripici@musc.edu.
² Biodesix, Inc., Boulder, CO.
³ Department of Clinical Operations and Medical Affairs, AllerGenis, Hatfield, PA.
⁴ National Jewish Health, Denver, CO.
⁵ Cleveland Clinic Respiratory Institute, Denver, CO.
⁶ University of Pennsylvania, Philadelphia, PA.
⁷ Department of Medicine, Thoracic Oncology Research Group, Medical University of South Carolina, Charleston, SC.

Nichole T Tanner et al. Chest. 2021 Mar.

. 2021 Mar;159(3):1283-1287.

doi: 10.1016/j.chest.2020.10.069. Epub 2020 Nov 7.

¹ Health Equity and Rural Outreach Innovation Center (HEROIC), Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC; Department of Medicine, Thoracic Oncology Research Group, Medical University of South Carolina, Charleston, SC. Electronic address: tripici@musc.edu.
² Biodesix, Inc., Boulder, CO.
³ Department of Clinical Operations and Medical Affairs, AllerGenis, Hatfield, PA.
⁴ National Jewish Health, Denver, CO.
⁵ Cleveland Clinic Respiratory Institute, Denver, CO.
⁶ University of Pennsylvania, Philadelphia, PA.
⁷ Department of Medicine, Thoracic Oncology Research Group, Medical University of South Carolina, Charleston, SC.

No abstract available

Publication types